DE60019314D1 - Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen - Google Patents

Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen

Info

Publication number
DE60019314D1
DE60019314D1 DE60019314T DE60019314T DE60019314D1 DE 60019314 D1 DE60019314 D1 DE 60019314D1 DE 60019314 T DE60019314 T DE 60019314T DE 60019314 T DE60019314 T DE 60019314T DE 60019314 D1 DE60019314 D1 DE 60019314D1
Authority
DE
Germany
Prior art keywords
treatment
circulation
plant extracts
antioxidant based
search problems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60019314T
Other languages
English (en)
Other versions
DE60019314T2 (de
Inventor
Gianfranco Merizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceteris Holding Amsterdam BV
Original Assignee
Ceteris Holding Amsterdam BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceteris Holding Amsterdam BV filed Critical Ceteris Holding Amsterdam BV
Application granted granted Critical
Publication of DE60019314D1 publication Critical patent/DE60019314D1/de
Publication of DE60019314T2 publication Critical patent/DE60019314T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DE60019314T 1999-09-10 2000-09-08 Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen Expired - Fee Related DE60019314T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH166399 1999-09-10
CH166399 1999-09-10
PCT/EP2000/008875 WO2001019158A2 (en) 1999-09-10 2000-09-08 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems

Publications (2)

Publication Number Publication Date
DE60019314D1 true DE60019314D1 (de) 2005-05-12
DE60019314T2 DE60019314T2 (de) 2006-04-27

Family

ID=4215722

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60019314T Expired - Fee Related DE60019314T2 (de) 1999-09-10 2000-09-08 Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen

Country Status (8)

Country Link
US (1) US6756065B1 (de)
EP (1) EP1214084B1 (de)
JP (1) JP2003509344A (de)
AT (1) ATE292469T1 (de)
AU (1) AU776037B2 (de)
BR (1) BR0014262A (de)
DE (1) DE60019314T2 (de)
WO (1) WO2001019158A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
JP2004517801A (ja) * 2000-04-18 2004-06-17 セテリス・ホールディング・ベスローテン・フェンノートシャップ−アムステルダム（オランダ）−スックルサーレ・ディ・ルガーノ 皮膚のしわの予防または治療に有用な天然抽出物に基づく組成物
US6610277B2 (en) * 2000-12-27 2003-08-26 Arthur Zuckerman Appetite suppressant toothpaste
US6485710B2 (en) * 2000-12-27 2002-11-26 Arthur Zuckerman Appetite suppressant toothpaste
ITMI20011182A1 (it) 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
JP4179765B2 (ja) * 2001-07-19 2008-11-12 花王株式会社 脂質代謝改善剤
JP2004035417A (ja) * 2002-06-28 2004-02-05 Kao Corp 血中総ケトン体濃度上昇剤
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
US20040151794A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Method of improvement of blood circulation
WO2004112777A1 (ja) * 2003-06-20 2004-12-29 Mochida Pharmaceutical Co., Ltd. 下肢静脈瘤予防・治療用組成物
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
CA2551787C (en) * 2004-02-19 2014-04-08 Boehringer Ingelheim International Gmbh Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
EP1755547B1 (de) 2004-06-15 2010-09-08 The Boots Company PLC Haarpflegezusammensetzungen und verfahren
DE102004056838A1 (de) * 2004-08-25 2006-03-02 Gottfried Willmen Mittel zur Behandlung von Pruritus ani und Haemorrhoidalleiden
US20060088617A1 (en) * 2004-10-23 2006-04-27 Mccurry James M Chocolate composition and method for benefiting the cardiovascular system
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
ITMI20060136A1 (it) * 2006-01-27 2007-07-28 Pharmextracta S R L Composizioni a base di derivati della ginkgo biloba per il trattamento di condizioni asmatiche e allergiche
JP5054499B2 (ja) * 2007-12-10 2012-10-24 花王株式会社 脂質代謝改善剤
JP5711231B2 (ja) * 2009-08-12 2015-04-30 ホーファグ リサーチ アイピー （ピーワイシー） リミテッド アテローム性動脈硬化症などの心血管障害の処置のためのピクノジェノールまたはブドウ種子などのプロアントシアニジンとＣｅｎｔｅｌｌａａｓｉａｔｉｃａとの組み合わせ
DE102009028996A1 (de) * 2009-08-28 2011-03-03 Rovi Cosmetics International Gmbh Kosmetische Formulierung zur Reduktion der äußeren Erscheinungsbilder von Cellulite oder Orangenhaut
IT1402672B1 (it) * 2010-11-08 2013-09-13 Medestea Biotech S P A Composizioni comprendenti principi attivi di origine vegetale associati o meno a promotori e/o protettori di ossido nitrico per il trattamento e la prevenzione dei deficit erettili e dell' impotenza e per il potenziamento della performance sportiva
CN103976907B (zh) * 2014-05-29 2017-04-05 暨南大学 一种包含具有舒缓抗敏作用的组合物的化妆品、其制备方法及应用
CN110664845B (zh) * 2019-08-29 2021-08-17 北京化工大学 一种金枪鱼蛋白水解物和芍药苷的协同抗氧化组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
US4753929A (en) * 1986-03-12 1988-06-28 Daicel Chemical Industries, Ltd. Flavone glycoside
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
BR0014263A (pt) 1999-09-10 2002-07-09 Cetteris Holding B V Amsterdam Preparação antioxidante baseada em extratos vegetais para o tratamento de problemas degenerativos crÈnicos e circulatórios e de hipertensão

Also Published As

Publication number Publication date
DE60019314T2 (de) 2006-04-27
EP1214084A2 (de) 2002-06-19
AU7418800A (en) 2001-04-17
BR0014262A (pt) 2002-07-09
US6756065B1 (en) 2004-06-29
ATE292469T1 (de) 2005-04-15
AU776037B2 (en) 2004-08-26
WO2001019158A3 (en) 2002-02-21
EP1214084B1 (de) 2005-04-06
WO2001019158A2 (en) 2001-03-22
JP2003509344A (ja) 2003-03-11

Similar Documents

Publication Publication Date Title
DE60019314D1 (de) Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen
Shavandi et al. Polyphenol uses in biomaterials engineering
Duarte et al. Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
AR008685A1 (es) Composicion con actividad hipoalergenica o inmunomoduladora o que destina para el tratamiento de piel sensible, y uso de dicha composicion para la preparacion de un medicamento para el tratamiento de la piel sensible y/o alergica
BR0302672A (pt) Formulação farmacêutica nutriente compreendendo polifenóis e seus usos no tratamento de câncer
DE60004374D1 (de) Zusammensetzung zur behandlung von infektionen bei mensch und tier
NO20051665L (no) Antibiotiske mikrosfaerer for behandling av infeksjoner og osteomyelitt
ATE282317T1 (de) Antimikrobielle zusammensetzung zur behandlung von rindermastitis
ATE536858T1 (de) Zubereitung auf basis natürlicher extrakte zur vorbeugung und behandlung von hautfalten
EP1095660A3 (de) Therapeutisch wirksame Kombination welche Terpinen-4-ol und Arzneipflanzen enthalt
ATE287723T1 (de) Ein antioxydierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und chronischen degenerativen problemen und von bluthochdruck
EP1389468A4 (de) Zusammensetzungen zur förderung der knochenfrakturheilung
ATE410172T1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
BRPI0415004A (pt) implante bioartificial e seu uso e método de redução do risco de formação de tecido conjuntivo após o implante
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
ATE303816T1 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
WO2003082263A8 (en) Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
ATE357925T1 (de) Orale zusammensetzungen zur behandlung von cellulitis
Park Inhibitory effects of Korean plant resources on human immunodeficiency virus type 1 protease activity
DE60033699D1 (de) Kräuterzusammensetzung enthaltend calendula und eucalyptus für die behandlung und heilung von erkrankungen
KR930017583A (ko) 생약을 이용한 방향성 방취제
BR0215352A (pt) Composição farmacêutica que compreende um inibidor de alfa-glicosidase e um ácido 4-oxobutanóico, e seu uso para tratar diabetes
BR0202358A (pt) Gel para tratamento de estrias
ATE361086T1 (de) Pharmazeutische zusammensetzungen rutin und lespedeza capitata extrakt enthaltend zur behandlung von ödemen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee